Trade USANA Health Sciences, Inc. - USNA CFD

Trading Conditions

• Spread: 0.15
• Long position overnight feeLong position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position-0.026179 %(-$1.05)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position0.003957 %($0.16)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-$1.05)

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  ($0.16)

Key Stats

• Prev. Close: 45.43
• Open: 45.51
• 1-Year Change: -32.02%
• Day's Range: 45.51 - 47.25

USANA Health Sciences, Inc. Company profile

About USANA Health Sciences, Inc.

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

Financial summary

BRIEF: For the fiscal year ended 01 January 2022, USANA Health Sciences, Inc. revenues increased 5% to $1.19B. Net income decreased 7% to $116.5M. Revenues reflect USANA® Nutritionals segment increase of 6% to $1.02B, USANA Foods segment increase of 5% to $83.1M, China segment increase of 6% to $563.5M, North Asia segment increase of 13% to $129.9M. Net income was offset by Associate incentives increase of 6% to $519.3M (expense), Selling/General/Admin.

Equity composition

Common Stock $.001 Par, 03/11, 50M auth., 15,843,837 o/s. Insiders control approx 53.74%. 1/93, spun-off from Gull Laboratories, Inc. 10/03, 8/98, 2-for-1 stock splits.